DRD1
MOLECULAR TARGETdopamine receptor D1
DRD1 (dopamine receptor D1) is targeted by 106 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).
Compounds Targeting DRD1
Ranked by bioassay confidence score (PubChem active assay count × evidence quality).
Showing top 50 of 106 compounds. Use the BiohacksAI search to explore all DRD1 modulators.
About DRD1 as a Drug Target
DRD1 (dopamine receptor D1) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 106 compounds with documented DRD1 interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.
DRD1 inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.